13F-HR filed by Ridgeback Capital Investments L.P.
Ridgeback Capital Investments L.P. filed this 13F-HR for the quarter ended 2012-12-31, filed 2014-05-15, with 2 holding rows worth $34,220,000.
- Accession
- 0001140361-14-021504
- Filer
- CIK 1423994
- Filed
- 2014-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2012
A holdings report, 2 entries on the cover page, a total value of $34,220,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $34,220,000 with VALUE read as thousands by filing date, 13F file number 028-12856. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerRidgeback Capital Management LP028-12280
- included managerRidgeback Capital Investments Ltd.028-12277
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 3,804,646 | $25,529,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 784,381 | $8,691,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-14-021504 | this filing | 2014-05-15 | acceptance time not in the bulk data set |